{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "S",
          "position": "2019"
        },
        "variant_string_id": "LRRK2 G2019S"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in LRRK2 are the most common monogenetic cause of Parkinson's disease (PD).",
          "judgment": "Yes",
          "reasoning": "The paper establishes that LRRK2 mutations are causally linked to PD, defining the disease mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In vitro analysis showed autokinase activity as well as phosphotransferase activity towards myelin basic protein, suggesting altered kinase activity is relevant to disease pathogenesis.",
          "judgment": "Yes",
          "reasoning": "Assessing kinase activity directly investigates a functional consequence potentially contributing to PD pathogenesis, aligning with the disease mechanism.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3a: Basic Controls and Replicates",
          "extracted_paper_info": "The text does not explicitly state the number of replicates or mention the use of controls for this specific analysis.",
          "judgment": "No",
          "reasoning": "The provided text does not contain information about the controls used in this assay."
        },
        {
          "step_name": "Step 3b: Accepted/Validated Assay",
          "extracted_paper_info": "The use of kinase activity assays for LRRK2 is a common approach in the field.",
          "judgment": "Yes",
          "reasoning": "Kinase assays are established in the field for characterizing LRRK2 function."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The G2019S variant exhibits increased kinase activity, supported by accepted kinase assay methodology, providing supporting evidence for pathogenicity."
    }
  ]
}